iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancerHui Li(Harbin Medical University), Xianyu Zhang(Harbin Medical University)NanoscaleDecember 12, 202510.1039/d5nr04841aCited by 2SaveCiteExport RISWatch citationsRelated PapersNovel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic Cancers|Molecular Cancer Therapeutics|2021|6